Harrow, Inc.
HROW
$33.46
$0.361.09%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/12/2026
-
MarketBeat
6/9/2026
-
TipRanks
6/4/2026
-
Insider Monkey
6/3/2026
-
TipRanks Financial Blog
5/27/2026
-
Globe Newswire
5/27/2026
-
MarketBeat
5/20/2026
-
Insider Monkey
5/19/2026
-
The Cerbat Gem
5/19/2026
-
Insider Monkey
5/17/2026
-
The Cerbat Gem
5/15/2026
-
The Cerbat Gem
5/14/2026
-
TipRanks Financial Blog
5/13/2026
-
Globe Newswire
5/13/2026
-
TipRanks Financial Blog
5/13/2026
-
TipRanks Financial Blog
5/12/2026
-
TipRanks Financial Blog
5/12/2026
-
TipRanks Financial Blog
5/12/2026
-
MarketBeat
5/12/2026
-
TipRanks Financial Blog
5/11/2026
-
Globe Newswire
5/6/2026
-
TipRanks Financial Blog
5/4/2026
-
The Cerbat Gem
5/4/2026
-
MarketBeat
5/3/2026
-
MarketBeat
4/30/2026
-
Insider Monkey
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, May 11, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 10 and 14 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
615 733 4730
Address
1A Burton Hills Boulevard
Nashville, TN 37215
Nashville, TN 37215
Country
Year Founded
Business Description
Sector
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through...
more